Publications
- Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results2013 | First Faculty of Medicine, Second Faculty of Medicine
- Expression of BCL-2 and BAX-1 genes in the tissue of Ta, T1 urothelial carcinoma and their prognostic value2013 | First Faculty of Medicine, Second Faculty of Medicine
- Association of Pax5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder2006 | Second Faculty of Medicine
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlation with pathological findings and clinical outcome2003 | Second Faculty of Medicine
- The expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder carcinoma tissue. Correlatuion with pathological findings and clinical outcome.2002 | Second Faculty of Medicine
- Prognostic significance of p53 mutations and expression of PAX5 and Shb in superficial bladder cancer2001 | Second Faculty of Medicine
- Expression of PAX5, p53 immunohistochemistry and p53 mutation analysis in superficial bladder cancerPublication without faculty affiliation
- p53 mutations and PAX5 and SHB genes expression in superficial bladder cancerPublication without faculty affiliation
- Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer2016 | First Faculty of Medicine, Second Faculty of Medicine
- MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection2016 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...